Antigens recognized by autologous antibody in patients with renal-cell carcinoma - PubMed

Affiliations

• PMID: 10508479
• DOI: 10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5

Antigens recognized by autologous antibody in patients with renal-cell carcinoma

M J Scanlan et al. Int J Cancer. 1999.

Abstract

The screening of cDNA expression libraries derived from human tumors with autologous antibody (SEREX) is a powerful method for defining the structure of tumor antigens recognized by the humoral immune system. Sixty-five distinct antigens (NY-REN-1 to NY-REN-65) reactive with autologous IgG were identified by SEREX analysis of 4 renal cancer patients and were characterized in terms of cDNA sequence, mRNA expression pattern, and reactivity with allogeneic sera. REN-9, -10, -19, and -26 have a known association with human cancer. REN-9 (LUCA-15) and REN-10 (gene 21) map to the small cell lung cancer tumor suppressor gene locus on chromosome 3p21.3. REN-19 is equivalent to LKB1/STK11, a gene that is defective in Peutz-Jeghers syndrome and cancer. REN-26 is encoded by the bcr gene involved in the [t(9:22)] bcr/abl translocation. Genes encoding 3 of the antigens in the series showed differential mRNA expression; REN-3 displays a pattern of tissue-specific isoforms, and REN-21 and REN-43 are expressed at a high level in testis in comparison to 15 other normal tissues. The other 62 antigens were broadly expressed in normal tissues. With regard to immunogenicity, 20 of the 65 antigens reacted only with autologous sera. Thirty-three antigens reacted with sera from normal donors, indicating that their immunogenicity is not restricted to cancer. The remaining 12 antigens reacted with sera from 5-25% of the cancer patients but not with sera from normal donors. Seventy percent of the renal cancer patients had antibodies directed against one or more of these 12 antigens. Our results demonstrate the potential of the SEREX approach for the analysis of the humoral immune response against human cancer.

Similar articles

• Characterization of human colon cancer antigens recognized by autologous antibodies.

  Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. Scanlan MJ, et al. Int J Cancer. 1998 May 29;76(5):652-8. doi: 10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p. Int J Cancer. 1998. PMID: 9610721

• Serological analysis of human renal cell carcinoma.

  Devitt G, Meyer C, Wiedemann N, Eichmüller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zöller M. Devitt G, et al. Int J Cancer. 2006 May 1;118(9):2210-9. doi: 10.1002/ijc.21626. Int J Cancer. 2006. PMID: 16331622

• Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.

  Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krähn G, Heilmann V, Gschwend J, Bergmann L, Döhner H, Schmitt M. Greiner J, et al. Exp Hematol. 2002 Sep;30(9):1029-35. doi: 10.1016/s0301-472x(02)00874-3. Exp Hematol. 2002. PMID: 12225794

• Analysis of the B-cell repertoire against antigens expressed by human neoplasms.

  Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M. Preuss KD, et al. Immunol Rev. 2002 Oct;188:43-50. doi: 10.1034/j.1600-065x.2002.18805.x. Immunol Rev. 2002. PMID: 12445280 Review.

• The reverse proteomics for identification of tumor antigens.

  Lee SY, Jeoung D. Lee SY, et al. J Microbiol Biotechnol. 2007 Jun;17(6):879-90. J Microbiol Biotechnol. 2007. PMID: 18050904 Review.

Cited by

• Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.

  Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ. Hendrickson SL, et al. PLoS One. 2010 Sep 21;5(9):e12862. doi: 10.1371/journal.pone.0012862. PLoS One. 2010. PMID: 20877624 Free PMC article.

• Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma.

  Tsai NM, Chen BM, Wei SL, Wu CW, Roffler SR. Tsai NM, et al. Clin Exp Metastasis. 2003;20(2):103-9. doi: 10.1023/a:1022616223359. Clin Exp Metastasis. 2003. PMID: 12705631

• Cancer/testis (CT) antigens: potential targets for immunotherapy.

  Caballero OL, Chen YT. Caballero OL, et al. Cancer Sci. 2009 Nov;100(11):2014-21. doi: 10.1111/j.1349-7006.2009.01303.x. Epub 2009 Aug 1. Cancer Sci. 2009. PMID: 19719775 Free PMC article. Review.

• Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage.

  Pavoni E, Vaccaro P, Pucci A, Monteriù G, Beghetto E, Barca S, Dupuis ML, De Pasquale Ceratti A, Lugini A, Cianfriglia M, Cortesi E, Felici F, Minenkova O. Pavoni E, et al. BMC Cancer. 2004 Nov 12;4:78. doi: 10.1186/1471-2407-4-78. BMC Cancer. 2004. PMID: 15541172 Free PMC article.

• Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.

  Qi W, Shao F, Huang Q. Qi W, et al. Med Sci Monit. 2017 Dec 19;23:6012-6018. doi: 10.12659/msm.907951. Med Sci Monit. 2017. PMID: 29257799 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal